Monitoring Drug-Induced Brain Activity Changes with Functional Ultrasound Imaging and Convolutional Neural Networks

Jared Deighton,Shan Zhong,Kofi Agyeman,Wooseong Choi,Charles Liu,Darrin Lee,Vasileios Maroulas,Vasileios Christopoulos

2024-10-12

Abstract:Functional ultrasound imaging (fUSI) is a cutting-edge technology that measures changes in cerebral blood volume (CBV) by detecting backscattered echoes from red blood cells moving within its field of view (FOV). It offers high spatiotemporal resolution and sensitivity, allowing for detailed visualization of cerebral blood flow dynamics. While fUSI has been utilized in preclinical drug development studies to explore the mechanisms of action of various drugs targeting the central nervous system, many of these studies have primarily focused on predetermined regions of interest (ROIs). This focus may overlook relevant brain activity outside these specific areas, which could influence the results. To address this limitation, we combined convolutional neural networks (CNNs) with fUSI to comprehensively understand the pharmacokinetic process of Dizocilpine, also known as MK-801, a drug that blocks the N-Methyl-D-aspartate (NMDA) receptor in the central nervous system. CNN and class activation mapping (CAM) revealed the spatiotemporal effects of MK-801, which originated in the cortex and propagated to the hippocampus, demonstrating the ability to detect dynamic drug effects over time. Additionally, CNN and CAM assessed the impact of anesthesia on the spatiotemporal hemodynamics of the brain, revealing no distinct patterns between early and late stages. The integration of fUSI and CNN provides a powerful tool to gain insights into the spatiotemporal dynamics of drug action in the brain. This combination enables a comprehensive and unbiased assessment of drug effects on brain function, potentially accelerating the development of new therapies in neuropharmacological studies.

Neurons and Cognition,Image and Video Processing,Medical Physics

What problem does this paper attempt to address?

The main problem that this paper attempts to solve is that existing functional ultrasound imaging (fUSI) studies mainly focus on preset regions of interest (ROIs) in drug development and may overlook the activities in other relevant brain regions. To address this limitation, the author combines convolutional neural network (CNN) with fUSI technology, aiming to comprehensively understand the impact of drugs on brain function, especially the mechanism of action of the drug Dizocilpine (also known as MK - 801). MK - 801 is a selective N - methyl - D - aspartic acid (NMDA) receptor antagonist and is often used in the study of schizophrenia models.

Through this method, the author hopes:

1. **Comprehensively evaluate drug effects**: Use CNN and class - activation mapping (CAM) techniques to detect and locate the spatio - temporal effects of MK - 801 in the brain, especially the propagation process from the cortex to the hippocampus.
2. **Evaluate the influence of anesthesia**: Simultaneously evaluate the influence of anesthesia on the spatio - temporal hemodynamics of the brain to exclude the potential interference of anesthesia on the results.
3. **Provide an unbiased analysis method**: By combining fUSI and CNN, propose a new method for comprehensively evaluating the impact of drugs on brain function without pre - specifying ROIs, thereby accelerating the development of new therapies in neuropharmacology research.

This method can not only detect the changes in brain activity caused by drugs but also accurately locate the spatial distribution of these changes, providing a new perspective for the study of drug - action mechanisms.